These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 4391331)

  • 1. Some cardiovascular actions of cyclizine, chlorcyclizine and homchlorcyclizine.
    Madan BR; Pendse VK
    Indian J Physiol Pharmacol; 1969 Jul; 13(3):113-21. PubMed ID: 4391331
    [No Abstract]   [Full Text] [Related]  

  • 2. Some pharmacological actions of cyclizine, chlorcyclizine and homchlorcyclizine.
    Pendse VK; Madan BR
    Indian J Physiol Pharmacol; 1969 Jan; 13(1):31-6. PubMed ID: 4390896
    [No Abstract]   [Full Text] [Related]  

  • 3. Antiarrhythmic, anticonvulsant and local anaesthetic activity of cyclizine, chlorcyclizine and homchlorcyclizine.
    Madan BR; Pendse VK
    Indian Heart J; 1970 Jan; 22(1):3-10. PubMed ID: 4395443
    [No Abstract]   [Full Text] [Related]  

  • 4. [Pharmacological study of pipratecol (JP 711) and of a pharmaceutical combination raubasine-JP 711].
    Laubie M; Le Douarec JC
    Arzneimittelforschung; 1969 Nov; 19(11):1820-6. PubMed ID: 4391788
    [No Abstract]   [Full Text] [Related]  

  • 5. Mechanism of circulatory effects of chlorcyclizine.
    Sinha JN; Shamsi MA; Gupta ML; Kohli RP
    Eur J Pharmacol; 1971; 15(3):386-8. PubMed ID: 4400710
    [No Abstract]   [Full Text] [Related]  

  • 6. [Comparative studies on papaverine and N-methyl-beta, beta-diphenyldiethylamino chlorhydrate in their effect on the cardiovascular-system in anesthetized cats].
    Stremmel D; Grisk A; Scheler W
    Pharmazie; 1968 Jul; 23(7):373-6. PubMed ID: 5700483
    [No Abstract]   [Full Text] [Related]  

  • 7. PHYSIOLOGICAL DISTRIBUTION AND METABOLIC INACTIVATION OF CHLORCYCLIZINE AND CYCLIZINE.
    KUNTZMAN R; KLUTCH A; TSAI I; BURNS JJ
    J Pharmacol Exp Ther; 1965 Jul; 149():29-35. PubMed ID: 14334288
    [No Abstract]   [Full Text] [Related]  

  • 8. Cardiovascular effects of hexafluorodiethyl ether.
    Adler MW; Reidenberg MM; Harakal C; Rusy BF; Papacostas CA
    Int J Neuropsychiatry; 1965 Oct; 1(5):511-2. PubMed ID: 5858890
    [No Abstract]   [Full Text] [Related]  

  • 9. Drug-induced and naturally occurring myeloid bodies.
    Hruban Z; Slesers A; Hopkins E
    Lab Invest; 1972 Jul; 27(1):62-70. PubMed ID: 4402449
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of cyclizine hydrochloride and chlorcyclizine hydrochloride upon vestibular function.
    GUTNER LB; GOULD WJ; CRACOVANER AJ
    AMA Arch Otolaryngol; 1954 Apr; 59(4):503-9. PubMed ID: 13147636
    [No Abstract]   [Full Text] [Related]  

  • 11. [Experimental study of pharmacological properties of nialamide].
    Gilev AP; Terekhina AI; Tarasova EI; Khavronina ZP
    Farmakol Toksikol; 1967; 30(3):328-31. PubMed ID: 4386187
    [No Abstract]   [Full Text] [Related]  

  • 12. [On the measurement of sedative effects by hemodynamic methods].
    Klein K
    Arzneimittelforschung; 1969 Mar; 19(3):361-3. PubMed ID: 4388762
    [No Abstract]   [Full Text] [Related]  

  • 13. [Pharmacodynamic study of an alpha adrenolytic compound: acetoxy-thymoxy-ethyl-dimethylamine. II. Pharmacological study].
    Mercier J; Canellas J; Roquebert J
    Therapie; 1971; 26(4):785-94. PubMed ID: 4399130
    [No Abstract]   [Full Text] [Related]  

  • 14. [Animal experiment studies on the circulatory effect of ketamine and barbiturate in hemorrhagic shock].
    Patschke D; Reinecke A; Tarnow J; Eberlein HJ; Brückner JB
    Anaesthesist; 1972 May; 21(5):205-9. PubMed ID: 4558604
    [No Abstract]   [Full Text] [Related]  

  • 15. [Antiemetics and emetics. 26].
    Sachweh H
    Pharm Prax; 1968; 6():140-5. PubMed ID: 4387824
    [No Abstract]   [Full Text] [Related]  

  • 16. A role for the central histaminergic system in the leptin-mediated increase in cardiovascular dynamics.
    Rao SP; Dunbar JC
    Brain Res Bull; 2005 Jan; 64(5):425-32. PubMed ID: 15607830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacology of N-(2-picolyl)-N-phenyl-N-(2-piperidinoethyl)amine (TAT-3), a new antitussive agent.
    Kasé Y; Yuizono T; Tachibana K; Miyata T; Kito G; Miyano S
    Arzneimittelforschung; 1969 Dec; 19(12):1916-27. PubMed ID: 4392320
    [No Abstract]   [Full Text] [Related]  

  • 18. Inhibition of sympathomimetic effects on the cardiovascular system by 4-(2-isopropylamino-1-hydroxyethyl)methanesulfonanilide hydrochloride (MJ 1999).
    Aramendía P; Kaumann AJ
    J Pharmacol Exp Ther; 1967 Feb; 155(2):259-66. PubMed ID: 6025517
    [No Abstract]   [Full Text] [Related]  

  • 19. [Anti-inflammatory effect of badchizine].
    Antelava NA; Denisenko PP; Rozenberg VN
    Farmakol Toksikol; 1971; 34(2):185-8. PubMed ID: 5563390
    [No Abstract]   [Full Text] [Related]  

  • 20. [Cardiovascular effects of trazodone in humans. Study of 10 patients].
    Allaria B; Favaro M; Arienta R; Dei Poli M; Trivellato A; Brioschi F
    Minerva Anestesiol; 1983; 49(1-2):1-6. PubMed ID: 6835524
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.